US6635632B1
(en)
|
1996-12-23 |
2003-10-21 |
Athena Neurosciences, Inc. |
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
US6509331B1
(en)
|
1998-06-22 |
2003-01-21 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
US6774125B2
(en)
|
1998-06-22 |
2004-08-10 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
AU4707999A
(en)
*
|
1998-06-22 |
2000-01-10 |
Elan Pharmaceuticals, Inc. |
Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
|
JP2002518451A
(ja)
*
|
1998-06-22 |
2002-06-25 |
エラン ファーマシューティカルズ,インコーポレイテッド |
環状アミノ酸化合物およびその医薬組成物、並びにそれら化合物を用いたβ−アミロイドペプチドの放出および/またはその合成を阻害する方法
|
US6552013B1
(en)
|
1998-06-22 |
2003-04-22 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
WO1999067220A1
(en)
*
|
1998-06-22 |
1999-12-29 |
Elan Pharmaceuticals, Inc. |
Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
|
US6958330B1
(en)
|
1998-06-22 |
2005-10-25 |
Elan Pharmaceuticals, Inc. |
Polycyclic α-amino-ε-caprolactams and related compounds
|
NZ509241A
(en)
|
1998-08-07 |
2003-08-29 |
Du Pont Pharm Co |
Succinoylamino lactams as inhibitors of alpha-beta protein production
|
HRP990246A2
(en)
|
1998-08-07 |
2000-06-30 |
Du Pont Pharm Co |
Succinoylamino benzodiazepines as inhibitors of a beta protein production
|
US6486350B1
(en)
|
1998-09-30 |
2002-11-26 |
Elan Pharmaceuticals Inc. |
Biological reagents and methods for determining the mechanism in the generation of β-amyloid peptide
|
IL142816A0
(en)
|
1998-12-24 |
2002-03-10 |
Du Pont Pharm Co |
SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
|
AU773538B2
(en)
|
1999-01-22 |
2004-05-27 |
Elan Pharmaceuticals, Inc. |
Acyl derivatives which treat VLA-4 related disorders
|
US6503902B2
(en)
|
1999-09-13 |
2003-01-07 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production
|
US6960576B2
(en)
|
1999-09-13 |
2005-11-01 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
|
US6503901B1
(en)
|
1999-10-08 |
2003-01-07 |
Bristol Myers Squibb Pharma Company |
Amino lactam sulfonamides as inhibitors of Aβ protein production
|
CN1434706A
(zh)
|
1999-12-23 |
2003-08-06 |
神经化学公司 |
用于调节脑淀粉状蛋白性血管病的化合物和方法
|
JP2003523345A
(ja)
|
2000-02-17 |
2003-08-05 |
ブリストル−マイヤーズ スクイブ ファーマ カンパニー |
Aβタンパク質産生の阻害剤としてのスクシノイルアミノ炭素環および複素環
|
BR0110051A
(pt)
|
2000-04-03 |
2004-12-07 |
Bristol Myers Squibb Pharma Co |
Composto, uso do composto, composição farmacêutica e método de tratamento do mal de alzheimer
|
US6759404B2
(en)
|
2000-04-03 |
2004-07-06 |
Richard E. Olson |
Cyclic malonamides as inhibitors of aβ protein production
|
AU2001257006A1
(en)
|
2000-04-11 |
2001-10-23 |
Du Pont Pharmaceuticals Company |
Substituted lactams as inhibitors of abeta protein production
|
US6878363B2
(en)
|
2000-05-17 |
2005-04-12 |
Bristol-Myers Squibb Pharma Company |
Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging
|
MXPA02000862A
(es)
|
2000-06-01 |
2003-07-14 |
Bristol Myers Squibb Pharma Co |
Lactamas substituidas por succinatos ciclicos como inhibidores de la produccion de proteina abeta.
|
US6432944B1
(en)
|
2000-07-06 |
2002-08-13 |
Bristol-Myers Squibb Company |
Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives
|
CN100471838C
(zh)
*
|
2000-12-28 |
2009-03-25 |
第一制药株式会社 |
Vla-4抑制剂
|
ZA200304059B
(en)
*
|
2000-12-28 |
2004-07-06 |
Daiichi Seiyaku Co |
VLA-4 inhibitors.
|
AU2002357232A1
(en)
*
|
2001-12-04 |
2003-06-17 |
Elan Pharmaceuticals, Inc. |
Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
|
TW200307671A
(en)
|
2002-05-24 |
2003-12-16 |
Elan Pharm Inc |
Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
|
TWI281470B
(en)
|
2002-05-24 |
2007-05-21 |
Elan Pharm Inc |
Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
|
WO2004002478A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Elan Pharmaceuticals, Inc. |
Methods for treating alzheimer's disease using hydroxyethylene compounds containing a heterocyclic amide bond isostere
|
FR2842523A1
(fr)
|
2002-07-17 |
2004-01-23 |
Sanofi Synthelabo |
Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
|
CN1826336B
(zh)
|
2003-07-24 |
2010-06-02 |
第一制药株式会社 |
环己烷羧酸类
|
ATE502031T1
(de)
|
2005-09-29 |
2011-04-15 |
Elan Pharm Inc |
Carbamatverbindungen, die die durch vla-4 vermittelte leukozytenadhäsion inhibieren
|
JP5101512B2
(ja)
|
2005-09-29 |
2012-12-19 |
エラン ファーマシューティカルズ,インコーポレイテッド |
Vla−4によって媒介される白血球接着を阻害するピリミジニルアミド化合物
|
NZ570679A
(en)
|
2006-02-27 |
2011-01-28 |
Elan Pharm Inc |
Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated By VLA-4
|